Boost vaccine production, distribution and biopharma capacity
Bharatiya Janata Party · Lok Sabha General Election 2024
Last updated 8 Jul 2026
What does this status mean?
Meaningful delivery has occurred, but the stated commitment is incomplete.
Status describes delivery. Confidence describes how strong the available evidence is.
Original manifesto wording
“We will encourage and extend support to Bharatiya vaccine manufacturers and biopharma companies in various capacities to boost production and distribution and aim to reduce our timeline for vaccine manufacturing.”
Our Assessment
India retains a strong vaccine- and biopharma-manufacturing base (a leading global vaccine producer), and support continues through the National Biopharma Mission, the BioE3 Policy, PLI schemes for pharmaceuticals, and platforms for rapid vaccine development demonstrated during COVID-19 (Made-in-India vaccines). Efforts to expand production/distribution and shorten development timelines are ongoing rather than tied to a single completed deliverable. Partial.
Sources & Evidence
Related Promises

Have evidence on this promise?
Help us track this promise by submitting news articles, government orders, or any other evidence you've found.
Submit Evidence